Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.01 is in line with its 5-year average of 9.81, around the middle of its 5-year range (6.28–17.09).
As of the fiscal period ended Tuesday, June 30, 2026. 4.41% above its 12-month average of 9.59.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.01.
CURRENT RATIO
10.01
CURRENT RATIO AVG TTM
9.59
CURRENT RATIO AVG 3Y
9.70
CURRENT RATIO AVG 5Y
9.81
CURRENT RATIO AVG 10Y
9.21
CURRENT RATIO AVG 15Y
8.39
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.41%
CURRENT VS 3Y AVG
+3.15%
CURRENT VS 5Y AVG
+2.05%
CURRENT VS 10Y AVG
+8.65%
CURRENT VS 15Y AVG
+19.33%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+166.22%
vs the sector median at left
Market Cap
$1.61B
Current Ratio
13.11
TTM Avg
13.03
3Y Avg
9.21
5Y Avg
8.89
Market Cap
$1.59B
Current Ratio
4.69
TTM Avg
5.56
3Y Avg
3.02
5Y Avg
3.21
Market Cap
$1.63B
Current Ratio
2.91
TTM Avg
2.71
3Y Avg
3.12
5Y Avg
3.05
Market Cap
$1.57B
Current Ratio
7.69
TTM Avg
5.54
3Y Avg
6.46
5Y Avg
10.83
Market Cap
$1.54B
Current Ratio
6.77
TTM Avg
5.11
3Y Avg
9.27
5Y Avg
12.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| uniQure N.V. (QURE) | $1.60B | 10.01 | 9.59 | 9.70 | 9.81 |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | 13.11 | 13.03 | 9.21 | 8.89 |
| Septerna Inc (SEPN)vs › | $1.61B | 4.99 | 16.25 | 13.64 | 13.64 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | 4.69 | 5.56 | 3.02 | 3.21 |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 1.64 | 1.40 | 1.84 | 1.88 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | 1.89 | 2.40 | 2.37 | 2.65 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 2.91 | 2.71 | 3.12 | 3.05 |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | 7.69 | 5.54 | 6.46 | 10.83 |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 6.77 | 5.11 | 9.27 | 12.43 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 16.01 | 8.50 | 7.33 | 23.22 |
Current Ratio
10.01
Quick Ratio
10.01
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.01 |
| 2026-03-31 | 10.40 |
| 2025-12-31 | 10.43 |
| 2025-09-30 | 7.12 |
| 2025-06-30 | 9.98 |
| 2025-03-31 | 11.99 |
| 2024-12-31 | 9.74 |
| 2024-09-30 | 6.51 |
| 2024-06-30 | 7.36 |
| 2024-03-31 | 9.39 |
| 2023-12-31 | 8.85 |
| 2023-09-30 | 10.11 |
| 2023-06-30 | 11.07 |
| 2023-03-31 | 6.67 |
| 2022-12-31 | 6.28 |
| 2022-09-30 | 7.26 |
| 2022-06-30 | 10.84 |
| 2022-03-31 | 12.94 |
| 2021-12-31 | 17.09 |
| 2021-09-30 | 14.17 |
| 2021-06-30 | 15.06 |
| 2021-03-31 | 8.79 |
| 2020-12-31 | 9.47 |
| 2020-09-30 | 8.62 |
| 2020-06-30 | 10.71 |
| 2020-03-31 | 12.89 |
| 2019-12-31 | 12.15 |
| 2019-09-30 | 14.33 |
| 2019-06-30 | 8.07 |
| 2019-03-31 | 9.51 |
| 2018-12-31 | 11.85 |
| 2018-09-30 | 7.56 |
| 2018-06-30 | 8.36 |
| 2018-03-31 | 5.48 |
| 2017-12-31 | 8.47 |
| 2017-09-30 | 3.64 |
| 2017-06-30 | 4.82 |
| 2017-03-31 | 6.04 |
| 2016-12-31 | 6.34 |
| 2016-09-30 | 7.33 |
| 2016-06-30 | 7.92 |
| 2016-03-31 | 7.17 |
| 2015-12-31 | 8.59 |
| 2015-09-30 | 9.27 |
| 2015-06-30 | 8.39 |
| 2015-03-31 | 3.15 |
| 2014-12-31 | 4.68 |
| 2014-09-30 | 6.03 |
| 2014-06-30 | 6.82 |
| 2014-03-31 | 5.83 |
| 2013-12-31 | 2.65 |
| 2013-09-30 | 3.93 |
| 2013-06-30 | 1.17 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.20 |
| 2012-09-30 | 0.00 |
